CoChat

In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer

The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.

Abstract

The immune system can eliminate tumors, but checkpoints enable immune escape. Here, we identify immune evasion mechanisms using genome-scale in vivo CRISPR screens across cancer models treated with immune checkpoint blockade (ICB). We identify immune evasion genes and important immune inhibitory checkpoints conserved across cancers, including the non-classical major histocompatibility complex class I (MHC class I) molecule Qa-1 b/HLA-E. Surprisingly, loss of tumor interferon-γ (IFNγ) signaling sensitizes many models to immunity. The immune inhibitory effects of tumor IFN sensing are mediated through two mechanisms. First, tumor upregulation of classical MHC class I inhibits natural killer cells. Second, IFN-induced expression of Qa-1 b inhibits CD8+ T cells via the NKG2A/CD94 receptor, which is induced by ICB. Finally, we show that strong IFN signatures are associated with poor response to ICB in individuals with renal cell carcinoma or melanoma. This study reveals that IFN-mediated upregulation of classical and non-classical MHC class I inhibitory checkpoints can facilitate immune escape.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41590-022-01315-x

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 84 references

Research works printed but not linked: 1

  1. Kossaifi, J., Panagakis, Y., Anandkumar, A. & Pantic, M. TensorLy: tensor learning in Python. J. Mach. Learn. Res. 20, 1–6 (2019).

Cited by

See all 224

Metadata

Authors
Dubrot, J., Du, P. P., Lane-Reticker, S. K., Kessler, E. A., Muscato, A. J., Mehta, A., Freeman, S. S., Allen, P. M., Olander, K. E., Ockerman, K. M., Wolfe, C. H., Wiesmann, F., Knudsen, N. H., Tsao, H.-W., Iracheta-Vellve, A., Schneider, E. M., Rivera-Rosario, A. N., Kohnle, I. C., Pope, H. W., Ayer, A., Mishra, G., Zimmer, M. D., Kim, S. Y., Mahapatra, A., Ebrahimi-Nik, H., Frederick, D. T., Boland, G. M., Haining, W. N., Root, D. E., Doench, J. G., Hacohen, N., Yates, K. B., & Manguso, R. T.
Affiliations
  • Broad Institute (US)
  • Massachusetts General Hospital (US)
Corresponding author
  • Yates, Kathleen B.
  • Manguso, Robert T.
Venue
Nature Immunology
Published
2022-09-23
Volume
23
Issue
10
Pages
1495-1506
ISSN
  • 1529-2908 (ISSN-L)
  • 1529-2916
OpenAlex
W4297088172
Cited by
218
References
81
Citations by year
2026: 50 · 2025: 62 · 2024: 62 · 2023: 39 · 2022: 5
FWCI
17.79
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Nature Immunology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Calico Life Sciences
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Keywords
tumor immune evasion, immune checkpoint blockade, interferon-gamma signaling, MHC class I, Qa-1b, HLA-E, natural killer cells, CD8+ T cells, immune evasion, renal cell carcinoma, melanoma, cancer immunotherapy response
MeSH terms
Immune Checkpoint Inhibitors, Humans, Interferon-gamma, Neoplasms, Histocompatibility Antigens Class I, CD8-Positive T-Lymphocytes, NK Cell Lectin-Like Receptor Subfamily C, Immune Evasion, Clustered Regularly Interspaced Short Palindromic Repeats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer. https://app.cochat.ai/papers/10.1038/s41590-022-01315-x
The paper
Dubrot, J., Du, P. P., Lane-Reticker, S. K., Kessler, E. A., Muscato, A. J., Mehta, A., Freeman, S. S., Allen, P. M., Olander, K. E., Ockerman, K. M., Wolfe, C. H., Wiesmann, F., Knudsen, N. H., Tsao, H.-W., Iracheta-Vellve, A., Schneider, E. M., Rivera-Rosario, A. N., Kohnle, I. C., Pope, H. W., . . . Manguso, R. T. (2022). In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer. Nature Immunology. https://doi.org/10.1038/s41590-022-01315-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.